Related Experiment Video
Updated: Mar 3, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic
Sherin Ali Nawaito1,2, Dharmendra Dingar1,3, Pramod Sahadevan1,3
1Montreal Heart Institute, Montréal, Québec, Canada.
Abstract:
MAPK-activated protein kinase-5 (MK5) is a protein serine/threonine kinase that is activated by p38 MAPK and the atypical MAPKs ERK3 and ERK4. The physiological function(s) of MK5 remains unknown. Here, we examined the effect of MK5 haplodeficiency on cardiac function and myocardial remodeling. At 12 wk of age, MK5 haplodeficient mice (MK5+/-) were smaller than age-matched wild-type littermates (MK5+/+), with similar diastolic function but reduced systolic function. Transverse aortic constriction (TAC) was used to induce chronic pressure overload in 12-wk-old male MK5+/- and MK5+/+ mice. Two weeks post-TAC, heart weight-to-tibia length ratios were similarly increased in MK5+/- and MK5+/+ hearts, as was the abundance of B-type natriuretic peptide and β-myosin heavy chain mRNA. Left ventricular ejection fraction was reduced in both MK5+/+ and MK5+/- mice, whereas regional peak systolic tissue velocities were reduced and isovolumetric relaxation time was prolonged in MK5+/+ hearts but not in MK5+/- hearts. The TAC-induced increase in collagen type 1-α1 mRNA observed in MK5+/+ hearts was markedly attenuated in MK5+/- hearts. Eight weeks post-TAC, systolic function was equally impaired in MK5+/+ and MK5+/- mice. In contrast, the increase in E wave deceleration rate and progression of hypertrophy observed in TAC MK5+/+ mice were attenuated in TAC MK5+/- mice. MK5 immunoreactivity was detected in adult fibroblasts but not in myocytes. MK5+/+, MK5+/-, and MK5-/- fibroblasts all expressed α-smooth muscle actin in culture. Hence, reduced MK5 expression in cardiac fibroblasts was associated with the attenuation of both hypertrophy and development of a restrictive filling pattern during myocardial remodeling in response to chronic pressure overload.NEW & NOTEWORTHY MAPK-activated protein kinase-5 (MK5)/p38-regulated/activated protein kinase is a protein serine/threonine kinase activated by p38 MAPK and/or the atypical MAPKs ERK3 and ERK4. MK5 immunoreactivity was detected in adult ventricular fibroblasts but not in myocytes. MK5 haplodeficiency attenuated the progression of hypertrophy, reduced collagen type 1 mRNA, and protected diastolic function in response to chronic pressure overload.
Insights
Reduced MAPK-activated protein kinase-5 (MK5) in mice lessened cardiac hypertrophy and diastolic dysfunction following pressure overload. This suggests MK5 in cardiac fibroblasts plays a key role in myocardial remodeling and heart failure progression.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Protein Kinase Signaling
Background:
- The physiological roles of MAPK-activated protein kinase-5 (MK5) are largely unknown.
- MK5 is activated by p38 MAPK and atypical MAPKs ERK3/ERK4.
- Understanding MK5's function is crucial for elucidating cardiac remodeling mechanisms.
Purpose of the Study:
- To investigate the impact of MK5 haplodeficiency on cardiac function and myocardial remodeling.
- To determine the role of MK5 in the response to chronic pressure overload.
- To identify the cellular localization and function of MK5 in the heart.
Main Methods:
- Utilized MK5 haplodeficient (MK5+/-) and wild-type (MK5+/+) mice.
- Induced chronic pressure overload using Transverse Aortic Constriction (TAC).
- Assessed cardiac function, hypertrophy markers, and collagen expression via molecular and physiological techniques.
Main Results:
- MK5 haplodeficiency attenuated TAC-induced cardiac hypertrophy and collagen type 1 mRNA expression.
- Reduced MK5 expression protected diastolic function and slowed the progression of hypertrophy post-TAC.
- MK5 was localized to adult cardiac fibroblasts, not myocytes.
Conclusions:
- Reduced MK5 expression in cardiac fibroblasts attenuates hypertrophy and restrictive filling patterns during pressure overload.
- MK5 plays a significant role in cardiac fibroblast-mediated myocardial remodeling.
- Targeting MK5 may offer a therapeutic strategy for heart failure with preserved ejection fraction.
More Related Videos
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
08:34Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care